The Food and Drug Administration will hold a two-day expert review on metal-on-metal hip replacements that may result in new standards for the device, according to a New York Times report.
The advisory panel will be held June 27 through June 28 and include scientists, researchers, patients and medical professionals. These experts will help regulators decide whether new testing and review requirements will be implemented before new metal-on-metal hip implants can be sold in the United States.
More Articles on Orthopedic Devices:
FDA Sends Warning Letters to California Orthopedic & Spine Device Companies
FDA Publishes Guidance for Pre-market Approvals
Wright Medical Group Names James Lightman Senior Vice President
More Articles on Orthopedic Devices:
FDA Sends Warning Letters to California Orthopedic & Spine Device Companies
FDA Publishes Guidance for Pre-market Approvals
Wright Medical Group Names James Lightman Senior Vice President